1
|
Inoue K, Muramatsu K, Nishimura T, Fujino Y, Matsuda S, Fushimi K, Kamochi M. Association between early diagnosis of and inpatient mortality from invasive pulmonary aspergillosis among patients without immunocompromised host factors: a nationwide observational study. Int J Infect Dis 2022; 122:279-284. [PMID: 35643307 DOI: 10.1016/j.ijid.2022.05.048] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 05/19/2022] [Accepted: 05/21/2022] [Indexed: 10/18/2022] Open
Abstract
OBJECTIVES The incidence of invasive pulmonary aspergillosis (IPA) among patients without immunocompromised host factors (ICHF) has been described extensively. However, its diagnosis remains challenging. To date, no study has statistically confirmed the efficacy of early IPA diagnosis in patients without ICHF. METHODS We conducted a cross-sectional study on mortality from IPA among patients without ICHF, using the Japanese Diagnosis Procedure Combination National Inpatient Database (April 2014-March 2018). The early diagnosis group was defined according to antifungal therapy initiation within 7 days of hospital admission. The delayed diagnosis group was defined according to antifungal therapy initiation between 8 and 28 days of the hospitalization. Associations were estimated using multivariate logistic regression. RESULTS A total of 423 patients were registered (early diagnosis group, n = 262, 62%). The early diagnosis group had a lower mortality rate (30%) than the delayed diagnosis group (42%). The early diagnosis group that was treated with voriconazole was associated with lower odds of mortality (odds ratio 0.55, 95% confidence interval 0.31-0.99, P = 0.047). An age of ≥65 years and mechanical ventilation were associated with a higher mortality rate. CONCLUSION Early diagnosis along with optimal antifungal treatment are crucial for achieving favorable outcomes among patients with IPA without ICHF.
Collapse
Affiliation(s)
- Katsuhiro Inoue
- Intensive Care Unit, Hospital of University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi, Kitakyushu, 8078555, Japan.
| | - Keiji Muramatsu
- Department of Preventive Medicine and Community Health, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi,, 8078555, Japan
| | - Takehiro Nishimura
- Department of Preventive Medicine and Community Health, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi,, 8078555, Japan
| | - Yoshihisa Fujino
- Department of Environmental Epidemiology, Institute of industrial Ecological Sciences, University of Occupational and Environmental Health, 11 Iseigaoka, Yahatanishi, Kitakyushu, 8078555, Japan
| | - Shinya Matsuda
- Department of Preventive Medicine and Community Health, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi,, 8078555, Japan
| | - Kiyohide Fushimi
- Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School, 1 5-45 Yushima, Bunkyo-ku, Tokyo, 1138510, Japan
| | - Masayuki Kamochi
- Intensive Care Unit, Hospital of University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi, Kitakyushu, 8078555, Japan
| |
Collapse
|
2
|
Watanabe N, Saito K, Kiritani A, Fujimoto S, Yamanaka Y, Fujisaki I, Hosoda C, Miyagawa H, Seki Y, Kinoshita A, Takeda H, Endo Y, Kuwano K. A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient. J Infect Chemother 2019; 26:274-278. [PMID: 31542205 DOI: 10.1016/j.jiac.2019.08.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Revised: 07/26/2019] [Accepted: 08/16/2019] [Indexed: 10/26/2022]
Abstract
Invasive pulmonary aspergillosis (IPA) patients with non-hematological malignancy are far less than with hematological malignancy patients. We encountered a very rare case of IPA in which type 1 diabetes was the only conceivable risk factor. Further, according to the diagnostic categories of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) criteria for IPA, the frequency of proven diagnosis is very low. Here we report a proven IPA, which rapidly developed when the patient with type 1 diabetes was being treated for diabetic ketoacidosis, which was successfully treated with the combination therapy of voriconazole (VRCZ) and micafungin (MCFG), based on early diagnosis using bronchoscopy.
Collapse
Affiliation(s)
- Naoaki Watanabe
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan.
| | - Keisuke Saito
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Ayu Kiritani
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Shota Fujimoto
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Yumie Yamanaka
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Ikumi Fujisaki
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Chiaki Hosoda
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Hanae Miyagawa
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Yoshitaka Seki
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Akira Kinoshita
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Hiroshi Takeda
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Yasuhiko Endo
- Department of Pathology, The Jikei University Daisan Hospital, Tokyo, Japan
| | - Kazuyoshi Kuwano
- Division of Respiratory Medicine, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
| |
Collapse
|
3
|
Shah MM, Hsiao EI, Kirsch CM, Gohil A, Narasimhan S, Stevens DA. Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature. Diagn Microbiol Infect Dis 2018; 91:147-152. [PMID: 29454654 PMCID: PMC5970059 DOI: 10.1016/j.diagmicrobio.2018.01.014] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2017] [Revised: 01/10/2018] [Accepted: 01/17/2018] [Indexed: 01/20/2023]
Abstract
Invasive pulmonary aspergillosis (IPA) is classically considered an illness of severely immunocompromised patients with limited host defenses. However, IPA has been reported in immunocompetent but critically ill patients. This report describes two fatal cases of pathologically confirmed IPA in patients with influenza in the intensive care unit. One patient had influenza B infection, whereas the other had influenza A H1N1. Both patients died despite broad-spectrum antimicrobials, mechanical ventilation, and vasopressor support. Microscopic and histologic postmortem examination confirmed IPA. Review of the English language and foreign literature indicates that galactomannan antigen testing and classic radiologic findings for IPA may not be reliable in immunocompetent patients. Respiratory cultures which grow Aspergillus species in critically ill patients, particularly those with underlying influenza infection, should not necessarily be disregarded as contaminants or colonizers. Further research is needed to better understand the immunological relationship between influenza and IPA for improved prevention and treatment of influenza and Aspergillus co-infections.
Collapse
Affiliation(s)
- Melisa M Shah
- Santa Clara Valley Medical Center, 751 S. Bascom Ave, San Jose, CA, 95128-2699, USA; Stanford University School of Medicine, Department of Medicine, Stanford, CA 94305.
| | - Eric I Hsiao
- Santa Clara Valley Medical Center, 751 S. Bascom Ave, San Jose, CA, 95128-2699, USA; Stanford University School of Medicine, Department of Medicine, Stanford, CA 94305.
| | - Carl M Kirsch
- Santa Clara Valley Medical Center, 751 S. Bascom Ave, San Jose, CA, 95128-2699, USA; Stanford University School of Medicine, Department of Medicine, Stanford, CA 94305.
| | - Amit Gohil
- Santa Clara Valley Medical Center, 751 S. Bascom Ave, San Jose, CA, 95128-2699, USA; Stanford University School of Medicine, Department of Medicine, Stanford, CA 94305.
| | - Supriya Narasimhan
- Santa Clara Valley Medical Center, 751 S. Bascom Ave, San Jose, CA, 95128-2699, USA; Stanford University School of Medicine, Department of Medicine, Stanford, CA 94305.
| | - David A Stevens
- Stanford University School of Medicine, Department of Medicine, Stanford, CA 94305; California Institute for Medical Research, 2260 Clove Dr., San Jose 95128.
| |
Collapse
|
4
|
Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel) 2017; 3:E57. [PMID: 29371573 PMCID: PMC5753159 DOI: 10.3390/jof3040057] [Citation(s) in RCA: 1324] [Impact Index Per Article: 189.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Revised: 10/12/2017] [Accepted: 10/16/2017] [Indexed: 02/07/2023] Open
Abstract
Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are still a neglected topic by public health authorities even though most deaths from fungal diseases are avoidable. Serious fungal infections occur as a consequence of other health problems including asthma, AIDS, cancer, organ transplantation and corticosteroid therapies. Early accurate diagnosis allows prompt antifungal therapy; however this is often delayed or unavailable leading to death, serious chronic illness or blindness. Recent global estimates have found 3,000,000 cases of chronic pulmonary aspergillosis, ~223,100 cases of cryptococcal meningitis complicating HIV/AIDS, ~700,000 cases of invasive candidiasis, ~500,000 cases of Pneumocystis jirovecii pneumonia, ~250,000 cases of invasive aspergillosis, ~100,000 cases of disseminated histoplasmosis, over 10,000,000 cases of fungal asthma and ~1,000,000 cases of fungal keratitis occur annually. Since 2013, the Leading International Fungal Education (LIFE) portal has facilitated the estimation of the burden of serious fungal infections country by country for over 5.7 billion people (>80% of the world's population). These studies have shown differences in the global burden between countries, within regions of the same country and between at risk populations. Here we interrogate the accuracy of these fungal infection burden estimates in the 43 published papers within the LIFE initiative.
Collapse
Affiliation(s)
- Felix Bongomin
- The National Aspergillosis Center, Education and Research Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.
- Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
- Global Action Fund for Fungal Infections, 1211 Geneva 1, Switzerland.
| | - Sara Gago
- Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
- Global Action Fund for Fungal Infections, 1211 Geneva 1, Switzerland.
- Manchester Fungal Infection Group, Core Technology Facility, The University of Manchester, Manchester M13, 9PL, UK.
| | - Rita O Oladele
- Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
- Global Action Fund for Fungal Infections, 1211 Geneva 1, Switzerland.
| | - David W Denning
- The National Aspergillosis Center, Education and Research Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.
- Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
- Global Action Fund for Fungal Infections, 1211 Geneva 1, Switzerland.
- Manchester Fungal Infection Group, Core Technology Facility, The University of Manchester, Manchester M13, 9PL, UK.
| |
Collapse
|
5
|
Primary Duodenal Aspergillosis in a Patient With Alcoholic Cirrhosis and Poorly Controlled Diabetes Mellitus. ACG Case Rep J 2016; 3:e147. [PMID: 27847833 PMCID: PMC5104900 DOI: 10.14309/crj.2016.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2015] [Accepted: 03/11/2016] [Indexed: 11/17/2022] Open
|
6
|
Vohra S, Taylor R, Aronowitz P. The tell-tale heart: Aspergillus fumigatus endocarditis in an immunocompetent patient. Hosp Pract (1995) 2013; 41:117-121. [PMID: 23466974 DOI: 10.3810/hp.2013.02.1017] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Aspergillus is a saprophytic, spore-forming fungus that is ubiquitous in our daily environment. Inhalation of the airborne conidia leads to a variety of diseases, from asymptomatic colonization to disseminated disease. Immunocompromised patients are usually viewed as the population most susceptible to aspergillosis because of their lack of host immune defenses. However, a healthy immune system does not preclude an individual from susceptibility to aspergillosis. Our case illustrates an immunocompetent patient with disseminated aspergillosis involving the tricuspid valve. A high degree of suspicion is imperative in patients who present without the classic risk factors. Recognition of disseminated aspergillosis in such patients is necessary to promote early diagnosis, treatment, and improved outcomes in an otherwise fulminant, life-threatening infection.
Collapse
Affiliation(s)
- Sheba Vohra
- Department of Hospital-Based Specialists, Kaiser Permanente, Santa Rosa, CA, USA.
| | | | | |
Collapse
|